NDC product
TABLET, FILM COATED · Allergan, Inc.
NDC 0430-0473 · Allergan, Inc.
Key facts
| Product NDC | 0430-0473 |
|---|---|
| Nonproprietary name | Risedronate Sodium |
| Substances | RISEDRONATE SODIUM HEMI-PENTAHYDRATE, RISEDRONATE SODIUM MONOHYDRATE |
| Dosage form | TABLET, FILM COATED |
| Labeler | Allergan, Inc. |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | May 17, 2002 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: